FAQ
Investors

Why We Exist
Pipeline
The Pain Truth
About PAD
Our Company
ALT 5
News
FAQ
Investors
FOLLOW THE PROGRESS

Shareholder Letter

Investors

Overview
News & Events
Company Info
FAQ
Financial Info
Stock Data
SEC Filings
Governance
Contact Us

Company Info
Overview
Management Team
Presentations
Shareholder Letter
FAQ

Shareholder Letter (September 2020)

Sep 21, 2020

Shareholder Letter (September 2020)

Email Alerts
Tear Sheet
Contacts
RSS News Feed

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for prescribing dangerous opioid drugs. Our first drug candidate is a treatment for Peripheral Arterial Disease (PAD), a condition that can cause severe pain and affects over 8.5 million people in the US alone.

The company trades under the symbol JAN on the NASDAQ.

Latest News

JanOne on Twitter

Why We Exist
Pipeline
The Pain Truth
About PAD
Our Company
News
FAQs
Investors
Contact